SS Innovation International Inc. today announced that it has completed its first robotic cardiac surgery with its SSI Mantra 3 Surgical Robotic System in the US.

On 8 June, Dr. Juan Zuniga became the first surgeon to undergo a robotic cardiac surgery in the US and Western Hemisphere using a cardiothoresic surgeon at the Interhots at Guiyakil, Ecuador, Ecuador. A robotic atrial septal defects were closed in surgery. This process repairs a hole between the upper two chambers of the heart.

Dr. Zuniga said, “At the beginning of SSI Mantra in Latin American robotic surgery, we decided to take advantage of this advanced system in complex specialties, especially in cardiovascular surgery,” Dr. Zuniga said.

He said, “The experience was good, it was very easy to handle and manipulate the device, and the results were effective as we did a transsophageal echocardiogram to verify the complete bandage of communication between the two upper chambers of the heart,” he said. “We were very happy with the consequences of a successful closure, and the patient is recovering very well.”

SSI Mantra AIDS at minimum invasive processes

SSI is the first hospital in South America to install the mantra. It has performed a variety of complex surgical processes with surgical robots System Since its establishment.

“Because it is a minimum invasive process, recovery is very fast, very little bleeding, and since it is robotic, the tissue manipulation is very more accurate, and so it is suiting,” Dr. Zuniga said. “It assures the surgeon that every stitch made with the platform is kept right and without complexity.”

SS innovations described the SSI mantra as “a user friendly, modular, multi-arm system”. Its technology features include:

• Three to five modular robot weapons
• An open argonomic surgeon command center
• A large 3d 4k monitor
• A touch panel monitor for information display related to all patients
• A virtual real-time image of robotic patient-side arm cart
• Ability to superimpose 3D model for diagnostic imaging

A vision cart provides table-side team with the same uninterrupted 3D 4K scene as a surgeon to provide better safety and efficiency. The SSI Mantra uses more than 40 types of robotic endo-terrible devices to support various specialties including cardiac surgery. SS innovations said that this system has also been validly valid in India.

Now accept sessions presentations!

SS innovation crosses 4,000 robot surgery

Last month, SS innovation Announced That SSI mantra has been used in 4,000 surgery. These operations performed more than 100 different types of surgery without any complication, injuries or death penalty.

Fort Lauderdel, Fla.- Based Company This includes about 215 cardiac surgical processes. Six of these were successfully done through Telescare SSI Mantra 3 in India with a surgical robotic system.

Robot report Before Discussed Dr. Telescargary strategy of SS Innovation with Vishwasvastava, Chief Operating Officer and Chairman of the Board.

SS Innovation said it has developed a system to make robot surgery inexpensive and accessible for a large part of the global population. The company’s product range includes its ownership SSI mantra and its broad suite SSI money Tools, which support a variety of surgical processes.

The company released its latest system, SSI Mantra 3In July 2024. The system received regulatory approval for distance surgery and teleproosing from the Central Drugs Standard Control Organization (CDSCO). It opens the door for distance surgery and medical education.

In May 2025, SS innovation revealed There is a plan to present the US Food and Drug Administration for the system to submit a day novo classification request.

https://www.youtube.com/watch?v=i4c3exinyyw